<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Summary >
<Summary id="CDR0000258022" LegacyPDQID="3500" ReplacementFor="CDR0000062882"><SummaryMetaData><SummaryType>Treatment</SummaryType><SummaryAudience>Patients</SummaryAudience><SummaryLanguage>English</SummaryLanguage><SummaryDescription>Expert-reviewed information summary about the treatment of mycosis fungoides and the Sézary syndrome.</SummaryDescription><SummaryURL xref="http://cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq">Mycosis Fungoides and the Sezary Syndrome (PDQ®): Treatment</SummaryURL><MainTopics><TermRef ref="CDR0000038223">mycosis fungoides/Sezary syndrome</TermRef></MainTopics></SummaryMetaData><SummaryTitle>Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®)</SummaryTitle><AltTitle TitleType="Navlabel">Mycosis Fungoides &amp; Sézary Syndrome Treatment</AltTitle><AltTitle TitleType="Short">Mycosis Fungoides and the Sézary Syndrome Treatment</AltTitle><SummarySection id="_1"><Title>General Information About Mycosis Fungoides and the Sézary
		Syndrome</Title><SummarySection id="_3"><SectMetaData><SectionType>Organ description</SectionType><SectionType>Cancer description</SectionType></SectMetaData><KeyPoint id="_4">Mycosis fungoides and the Sézary syndrome are diseases in which
		  lymphocytes (a type of white blood cell) become malignant
		  (cancerous) and affect the skin.</KeyPoint><Para id="_121">Normally, the <GlossaryTermRef href="CDR0000045622">bone marrow</GlossaryTermRef> makes <GlossaryTermRef href="CDR0000765906">blood stem cells</GlossaryTermRef> (immature <GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef>) that become mature blood stem cells over time.  A blood stem cell may become a <GlossaryTermRef href="CDR0000046279">myeloid</GlossaryTermRef> <GlossaryTermRef href="CDR0000046598">stem cell</GlossaryTermRef> or a <GlossaryTermRef href="CDR0000046298">lymphoid</GlossaryTermRef> stem cell. A myeloid stem cell becomes a <GlossaryTermRef href="CDR0000046124">red blood cell</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045993">white blood cell</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000045840">platelet</GlossaryTermRef>.  A lymphoid stem cell becomes a <GlossaryTermRef href="CDR0000302475">lymphoblast</GlossaryTermRef> and then one of three types of <GlossaryTermRef href="CDR0000045765">lymphocytes</GlossaryTermRef> (white blood cells):</Para><ItemizedList id="_122" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000045611">B-cell</GlossaryTermRef> lymphocytes that make <GlossaryTermRef href="CDR0000044918">antibodies</GlossaryTermRef> to help fight <GlossaryTermRef href="CDR0000045364">infection</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000044928">T-cell</GlossaryTermRef> lymphocytes that help <GlossaryTermRef href="CDR0000044953">B-lymphocytes</GlossaryTermRef> make the antibodies that help fight infection.</ListItem><ListItem><GlossaryTermRef href="CDR0000044062">Natural killer cells</GlossaryTermRef> that attack <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef>  cells and <GlossaryTermRef href="CDR0000045941">viruses</GlossaryTermRef>.</ListItem></ItemizedList><MediaLink ref="CDR0000526538" type="image/jpeg" alt="Blood cell development; drawing shows the steps a blood stem cell goes through to become a red blood cell, platelet, or white blood cell. A myeloid stem cell becomes a red blood cell, a platelet, or a myeloblast, which then becomes a granulocyte (the types of granulocytes are eosinophils, basophils, and neutrophils). A lymphoid stem cell becomes a lymphoblast and then becomes a B-lymphocyte, T-lymphocyte, or natural killer cell." language="en" thumb="Yes" id="_145" size="three-quarters"><Caption language="en">Blood cell development. A blood stem cell goes through several steps to become a red blood cell, platelet, or white blood cell. </Caption></MediaLink><Para id="_123">In <GlossaryTermRef href="CDR0000045794">mycosis fungoides</GlossaryTermRef>, T-cell lymphocytes become cancerous and affect  the skin. In the <GlossaryTermRef href="CDR0000045878">Sézary syndrome</GlossaryTermRef>, cancerous T-cell lymphocytes affect the skin and are in the <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_9"><SectMetaData><SectionType>Cancer description</SectionType></SectMetaData><KeyPoint id="_10">Mycosis fungoides and the Sézary syndrome are types of cutaneous T-cell lymphoma. </KeyPoint><Para id="_11"> Mycosis fungoides and the Sézary syndrome are the two most common types of <GlossaryTermRef href="CDR0000046112">cutaneous</GlossaryTermRef> T-cell
		<GlossaryTermRef href="CDR0000045368">lymphoma</GlossaryTermRef> (a type of <GlossaryTermRef href="CDR0000045148">non-Hodgkin lymphoma</GlossaryTermRef>). For information about other types of <GlossaryTermRef href="CDR0000445084">skin cancer</GlossaryTermRef> or non-Hodgkin lymphoma, see the following <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> summaries:</Para><ItemizedList id="_106" Style="bullet"><ListItem><SummaryRef href="CDR0000062958" url="/types/lymphoma/patient/adult-nhl-treatment-pdq">Adult Non-Hodgkin Lymphoma Treatment</SummaryRef></ListItem><ListItem><SummaryRef href="CDR0000258035" url="/types/skin/patient/skin-treatment-pdq">Skin Cancer Treatment</SummaryRef></ListItem><ListItem><SummaryRef href="CDR0000062713" url="/types/skin/patient/melanoma-treatment-pdq">Melanoma Treatment</SummaryRef></ListItem><ListItem><SummaryRef href="CDR0000442381" url="/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq">Kaposi Sarcoma Treatment</SummaryRef></ListItem></ItemizedList></SummarySection><SummarySection id="_13"><SectMetaData><SectionType>Cancer description</SectionType><SectionType>Symptoms</SectionType></SectMetaData><KeyPoint id="_14">A sign of mycosis fungoides is a red rash on the skin.</KeyPoint><Para id="_108">Mycosis fungoides may go through  the following phases:</Para><ItemizedList id="_124" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000439417">Premycotic phase</GlossaryTermRef>: A scaly, red rash in areas of the body that usually are not exposed to the sun. This rash does not cause <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> and may last for months or years. It is hard to <GlossaryTermRef href="CDR0000046450">diagnose</GlossaryTermRef> the rash as mycosis fungoides during this phase.</ListItem><ListItem><GlossaryTermRef href="CDR0000729587">Patch</GlossaryTermRef> phase: Thin, reddened, <GlossaryTermRef href="CDR0000462675">eczema</GlossaryTermRef>-like rash.</ListItem><ListItem><GlossaryTermRef href="CDR0000439411">Plaque</GlossaryTermRef> phase: Small raised bumps (<GlossaryTermRef href="CDR0000729589">papules</GlossaryTermRef>) or hardened <GlossaryTermRef href="CDR0000046324">lesions</GlossaryTermRef> on the skin, which may be reddened. </ListItem><ListItem><GlossaryTermRef href="CDR0000046634">Tumor</GlossaryTermRef> phase: Tumors form on the skin. These tumors may develop <GlossaryTermRef href="CDR0000269469">ulcers</GlossaryTermRef> and the skin may get infected.</ListItem></ItemizedList><Para id="_173">Check with your doctor if you have any of these <GlossaryTermRef href="CDR0000750109">signs</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_125"><SectMetaData><SectionType>Cancer description</SectionType></SectMetaData><KeyPoint id="_126">In the Sézary syndrome, cancerous T-cells are found in the blood.</KeyPoint><Para id="_127">Also, skin all over the body is reddened, itchy, peeling, and painful. There may also be patches, plaques, or tumors on the skin.  It is not known if the Sézary syndrome is an advanced form of mycosis fungoides or a separate disease.</Para></SummarySection><SummarySection id="_16"><SectMetaData><SectionType>Diagnostic tests</SectionType></SectMetaData><KeyPoint id="_17">Tests that examine the skin and blood are used to detect (find)
		  and diagnose mycosis fungoides and the Sézary syndrome.</KeyPoint><Para id="_18">The following tests and procedures may be used:</Para><ItemizedList id="_19" Style="bullet" Compact="No"> 
		  <ListItem><Strong><GlossaryTermRef href="CDR0000270871">Physical exam</GlossaryTermRef> and <GlossaryTermRef href="CDR0000689078">history</GlossaryTermRef></Strong>: An exam of the body to check general signs of health, including checking for signs of disease, such as lumps, the number and type of skin lesions, or anything else that seems unusual. Pictures of the skin and a history of the patient’s health habits and  past illnesses and treatments will also be taken.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000729979">Complete blood count with differential</GlossaryTermRef></Strong>: A procedure in which a sample of blood is drawn and checked for the following:  
   <ItemizedList id="_114" Style="dash"><ListItem>The number of red blood cells and platelets.</ListItem><ListItem>The number and type of white blood cells.</ListItem><ListItem>The amount of <GlossaryTermRef href="CDR0000045108">hemoglobin</GlossaryTermRef> (the <GlossaryTermRef href="CDR0000046092">protein</GlossaryTermRef> that carries <GlossaryTermRef href="CDR0000538149">oxygen</GlossaryTermRef>) in the red blood cells. 
   </ListItem><ListItem>The portion of the blood sample made up of red blood cells. 
</ListItem></ItemizedList><MediaLink ref="CDR0000526546" type="image/jpeg" alt="Complete blood count (CBC); left panel shows blood being drawn from a vein on the inside of the elbow using a tube attached to a syringe; right panel shows a laboratory test tube with blood cells separated into layers: plasma, white blood cells, platelets, and red blood cells. " language="en" thumb="Yes" id="_140" size="three-quarters"><Caption language="en">Complete blood count (CBC). Blood is collected by inserting a needle into a vein and allowing the blood to flow into a tube. The blood sample is sent to the laboratory and the red blood cells, white blood cells, and platelets are counted.  The CBC is used to test for, diagnose, and monitor many different conditions.</Caption></MediaLink></ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000390307">Peripheral blood smear</GlossaryTermRef></Strong>: A procedure in which a sample of blood is viewed under a <GlossaryTermRef href="CDR0000638184">microscope</GlossaryTermRef> to count different circulating blood cells (red blood cells, white blood cells, platelets, etc.) and see whether the cells look normal. </ListItem> 
		  <ListItem><Strong>Skin <GlossaryTermRef href="CDR0000045164">biopsy</GlossaryTermRef></Strong>: The removal of cells or <GlossaryTermRef href="CDR0000046683">tissues</GlossaryTermRef> so they can be viewed under a microscope to check for signs of cancer. The doctor may remove a growth from the skin, which will be examined by a <GlossaryTermRef href="CDR0000046244">pathologist</GlossaryTermRef>.  More than one skin biopsy may be needed to diagnose mycosis fungoides.</ListItem><ListItem> <Strong><GlossaryTermRef href="CDR0000341450">Immunophenotyping</GlossaryTermRef></Strong>: A process used to identify cells, based on the types of <GlossaryTermRef href="CDR0000046086">antigens</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045776">markers</GlossaryTermRef> on the surface of the cell. This process may include special staining of the blood cells. It is used to diagnose specific types of <GlossaryTermRef href="CDR0000045343">leukemia</GlossaryTermRef> and lymphoma by comparing the cancer cells to normal cells of the <GlossaryTermRef href="CDR0000046356">immune system</GlossaryTermRef>.</ListItem><ListItem><Strong>T-cell <GlossaryTermRef href="CDR0000044958">receptor</GlossaryTermRef> (TCR) <GlossaryTermRef href="CDR0000045693">gene</GlossaryTermRef> rearrangement test</Strong>: A <GlossaryTermRef href="CDR0000046590">laboratory test</GlossaryTermRef> in which cells in a sample of tissue are checked to see if there is a certain change in the genes. This gene change can lead to too many of one kind of T-cells (white blood cells that fight infection) to be made.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000335066">Flow cytometry</GlossaryTermRef></Strong>: A laboratory test that measures the number of cells in a sample of blood, the percentage of live cells in a sample, and certain characteristics of cells, such as size, shape, and the presence of <GlossaryTermRef href="CDR0000046636">tumor markers</GlossaryTermRef> on the cell surface. The cells are stained with a light-sensitive dye, placed in a <GlossaryTermRef href="CDR0000044669">fluid</GlossaryTermRef>, and passed in a stream before a <GlossaryTermRef href="CDR0000045748">laser</GlossaryTermRef> or other type of light. The measurements are based on how the light-sensitive dye reacts to the light.</ListItem>
		   
		</ItemizedList></SummarySection><SummarySection id="_20"><SectMetaData><SectionType>Prognostic factors</SectionType></SectMetaData><KeyPoint id="_21">Certain factors affect prognosis (chance
		  of recovery) and treatment options.</KeyPoint><Para id="_103">The <GlossaryTermRef href="CDR0000045849">prognosis</GlossaryTermRef> (chance of <GlossaryTermRef href="CDR0000454708">recovery</GlossaryTermRef>) and treatment options depend on the following: </Para><ItemizedList id="_104" Style="bullet"><ListItem>The <GlossaryTermRef href="CDR0000045885">stage</GlossaryTermRef> of the cancer.</ListItem><ListItem>The type of lesion (patches, plaques, or tumors).</ListItem></ItemizedList><Para id="_119">Mycosis fungoides and the Sézary syndrome are hard to <GlossaryTermRef href="CDR0000318813">cure</GlossaryTermRef>. Treatment  is usually <GlossaryTermRef href="CDR0000045815">palliative</GlossaryTermRef>, to relieve symptoms and improve the <GlossaryTermRef href="CDR0000045417">quality of life</GlossaryTermRef>. Patients with early stage disease may live many years.</Para></SummarySection></SummarySection><SummarySection id="_26"><Title>Stages of Mycosis Fungoides and the Sézary Syndrome</Title><SummarySection id="_27"><SectMetaData><SectionType>Diagnostic tests</SectionType></SectMetaData><KeyPoint id="_28">After mycosis fungoides and the Sézary syndrome have been
		  diagnosed, tests are done to find out if cancer cells have spread from the skin to other parts of the body. </KeyPoint><Para id="_29">The process used to find out if <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> has spread from the skin to other parts
		  of the body is called <GlossaryTermRef href="CDR0000046597">staging</GlossaryTermRef>. The
		  information gathered from the staging process determines the
		  <GlossaryTermRef href="CDR0000045885">stage</GlossaryTermRef> of the disease. It is
		  important to know the stage in order to plan treatment. </Para><Para id="_182">The following
		  procedures may be used in the staging process:</Para><ItemizedList id="_30" Style="bullet" Compact="No"> 
		  <ListItem><Strong><GlossaryTermRef href="CDR0000304687">Chest x-ray</GlossaryTermRef></Strong>: An <GlossaryTermRef href="CDR0000045944">x-ray</GlossaryTermRef> of the <GlossaryTermRef href="CDR0000257523">organs</GlossaryTermRef> and bones inside the chest.  An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046033">CT scan</GlossaryTermRef> (CAT scan)</Strong>: A procedure that makes a series of detailed pictures of areas inside the body, such as the <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef>, chest, <GlossaryTermRef href="CDR0000045070">abdomen</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046246">pelvis</GlossaryTermRef>, taken from different angles.  The pictures are made by a computer linked to an x-ray machine. A <GlossaryTermRef href="CDR0000409764">dye</GlossaryTermRef> may be <GlossaryTermRef href="CDR0000044678">injected</GlossaryTermRef> into a <GlossaryTermRef href="CDR0000476471">vein</GlossaryTermRef> or swallowed to help the organs or <GlossaryTermRef href="CDR0000046683">tissues</GlossaryTermRef> show up more clearly.  This procedure is also called computed tomography, computerized tomography, or computerized axial tomography. </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046140">PET scan</GlossaryTermRef> (positron emission tomography scan)</Strong>: A procedure to find <GlossaryTermRef href="CDR0000045772">malignant</GlossaryTermRef> <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> <GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> in the body.  A small amount of <GlossaryTermRef href="CDR0000046550">radioactive</GlossaryTermRef> <GlossaryTermRef href="CDR0000044033">glucose</GlossaryTermRef> (sugar) is injected into a vein.  The PET <GlossaryTermRef href="CDR0000386220">scanner</GlossaryTermRef> rotates around the body and makes a picture of where glucose is being used in the body.  Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do.</ListItem><ListItem> <Strong>Lymph node
			 <GlossaryTermRef href="CDR0000045164">biopsy</GlossaryTermRef></Strong>: The
			 removal of all or part of a  lymph node. A <GlossaryTermRef href="CDR0000046244">pathologist</GlossaryTermRef> views the tissue under a <GlossaryTermRef href="CDR0000638184">microscope</GlossaryTermRef> to look for cancer cells.</ListItem> 
		<ListItem><Strong><GlossaryTermRef href="CDR0000669655">Bone marrow aspiration and biopsy</GlossaryTermRef></Strong>: The removal of <GlossaryTermRef href="CDR0000045622">bone marrow</GlossaryTermRef> and a small piece of bone by inserting a hollow needle into the hipbone or <GlossaryTermRef href="CDR0000549425">breastbone</GlossaryTermRef>. A pathologist views the bone marrow and bone under a microscope to look for signs of cancer.</ListItem></ItemizedList></SummarySection><SummarySection id="_146"><KeyPoint id="_147">There are three ways that cancer spreads in the body.</KeyPoint><Para id="_146_69">Cancer can spread through <GlossaryTermRef href="CDR0000046683">tissue</GlossaryTermRef>, the <GlossaryTermRef href="CDR0000045764">lymph system</GlossaryTermRef>, and the <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef>:</Para><ItemizedList id="_146_70" Style="bullet"><ListItem>Tissue. The cancer spreads from where it began by growing into nearby areas.
</ListItem><ListItem>Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the <GlossaryTermRef href="CDR0000269462">lymph vessels</GlossaryTermRef> to other parts of the body.
</ListItem><ListItem>Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the <GlossaryTermRef href="CDR0000045020">blood vessels</GlossaryTermRef> to other parts of the body.
</ListItem></ItemizedList></SummarySection><SummarySection id="_179"><KeyPoint id="_180">Cancer may spread from where it began to other parts of the body.</KeyPoint><Para id="_179_66">When cancer spreads to another part of the body, it is called <GlossaryTermRef href="CDR0000046710">metastasis</GlossaryTermRef>. Cancer <GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef> break away from where they began (the <GlossaryTermRef href="CDR0000045847">primary tumor</GlossaryTermRef>) and travel through the lymph system or blood.</Para><ItemizedList id="_179_67" Style="bullet"><ListItem>Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> (<GlossaryTermRef href="CDR0000044058">metastatic</GlossaryTermRef> tumor) in another part of the body.</ListItem><ListItem>Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.</ListItem></ItemizedList><Para id="_181">The metastatic tumor is the same type of cancer as the primary tumor. For example, if  <GlossaryTermRef href="CDR0000045794">mycosis fungoides</GlossaryTermRef> spreads to the <GlossaryTermRef href="CDR0000046312">liver</GlossaryTermRef>, the cancer cells in the liver are actually mycosis fungoides cells. The disease is metastatic mycosis fungoides, not liver cancer.</Para></SummarySection><SummarySection id="_31"><SectMetaData><SectionType>Classification by stage</SectionType></SectMetaData><KeyPoint id="_32">The following stages are used for mycosis fungoides and the
		  Sézary syndrome:</KeyPoint><SummarySection id="_33"><KeyPoint id="_34">Stage I Mycosis Fungoides</KeyPoint><Para id="_35"><GlossaryTermRef href="CDR0000454834">Stage I</GlossaryTermRef> is
			 divided into stage IA and stage IB as follows:</Para><ItemizedList id="_36" Style="bullet" Compact="No"> 
			 <ListItem><GlossaryTermRef href="CDR0000454834">Stage IA</GlossaryTermRef>: Less than 10% of the skin surface is covered with <GlossaryTermRef href="CDR0000729587">patches</GlossaryTermRef>, <GlossaryTermRef href="CDR0000729589">papules</GlossaryTermRef>, and/or <GlossaryTermRef href="CDR0000439411">plaques</GlossaryTermRef>. </ListItem> 
			 <ListItem><GlossaryTermRef href="CDR0000454834">Stage IB</GlossaryTermRef>: Ten percent or more of the skin surface is
				covered with <GlossaryTermRef href="CDR0000729587">patches</GlossaryTermRef>, <GlossaryTermRef href="CDR0000729589">papules</GlossaryTermRef>, and/or <GlossaryTermRef href="CDR0000439411">plaques</GlossaryTermRef>.</ListItem> 
		  </ItemizedList><Para id="_162">There may be <GlossaryTermRef href="CDR0000044636">abnormal</GlossaryTermRef> <GlossaryTermRef href="CDR0000045765">lymphocytes</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef> but they are not <GlossaryTermRef href="CDR0000045333">cancerous</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_37"><KeyPoint id="_38">Stage II Mycosis Fungoides</KeyPoint><Para id="_39"><GlossaryTermRef href="CDR0000454837">Stage II</GlossaryTermRef>
			 is divided into stage IIA and stage IIB as follows:</Para><ItemizedList id="_40" Style="bullet" Compact="No"> 
			 <ListItem><GlossaryTermRef href="CDR0000454837">Stage IIA</GlossaryTermRef>: Any amount of the skin surface is covered with <GlossaryTermRef href="CDR0000729587">patches</GlossaryTermRef>, <GlossaryTermRef href="CDR0000729589">papules</GlossaryTermRef>, and/or <GlossaryTermRef href="CDR0000439411">plaques</GlossaryTermRef>. <GlossaryTermRef href="CDR0000045762">Lymph nodes</GlossaryTermRef> are enlarged but <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> has not spread to them.</ListItem> 
			 <ListItem><GlossaryTermRef href="CDR0000454837">Stage IIB</GlossaryTermRef>: One or more <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef> that are 1 <GlossaryTermRef href="CDR0000354457">centimeter</GlossaryTermRef> or larger are found on the skin. <GlossaryTermRef href="CDR0000045762">Lymph nodes</GlossaryTermRef> may be enlarged but cancer has not spread to them.</ListItem> 
		  </ItemizedList><Para id="_163">There may be <GlossaryTermRef href="CDR0000044636">abnormal</GlossaryTermRef> <GlossaryTermRef href="CDR0000045765">lymphocytes</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef> but they are not cancerous.</Para></SummarySection><SummarySection id="_41"><KeyPoint id="_42">Stage III Mycosis Fungoides</KeyPoint><Para id="_43">In <GlossaryTermRef href="CDR0000454840">stage III</GlossaryTermRef>, nearly all of the skin is reddened and may have <GlossaryTermRef href="CDR0000729587">patches</GlossaryTermRef>, <GlossaryTermRef href="CDR0000729589">papules</GlossaryTermRef>, <GlossaryTermRef href="CDR0000439411">plaques</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef>. <GlossaryTermRef href="CDR0000045762">Lymph nodes</GlossaryTermRef> may be enlarged but <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef>  has not spread to them.</Para><Para id="_172">There may be <GlossaryTermRef href="CDR0000044636">abnormal</GlossaryTermRef> <GlossaryTermRef href="CDR0000045765">lymphocytes</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef> but they are not cancerous.</Para></SummarySection><SummarySection id="_44"><KeyPoint id="_45">Stage IV Mycosis Fungoides</KeyPoint><Para id="_46"><GlossaryTermRef href="CDR0000454841">Stage IV</GlossaryTermRef> is divided into stage IVA and stage IVB as follows:</Para><ItemizedList id="_47" Style="bullet" Compact="No"> 
			 <ListItem><GlossaryTermRef href="CDR0000454841">Stage IVA</GlossaryTermRef>: Most of the skin is reddened and any amount of the skin surface is covered with <GlossaryTermRef href="CDR0000729587">patches</GlossaryTermRef>, <GlossaryTermRef href="CDR0000729589">papules</GlossaryTermRef>, <GlossaryTermRef href="CDR0000439411">plaques</GlossaryTermRef>,  or <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef>, and either: <ItemizedList id="_164" Style="dash"><ListItem><GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> has spread to <GlossaryTermRef href="CDR0000045762">lymph nodes</GlossaryTermRef> and there may be cancerous <GlossaryTermRef href="CDR0000045765">lymphocytes</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef>; or</ListItem><ListItem>there are cancerous lymphocytes in the blood and lymph nodes may be enlarged, but cancer has not spread to them. </ListItem></ItemizedList></ListItem> 
			 <ListItem><GlossaryTermRef href="CDR0000454841">Stage IVB</GlossaryTermRef>: Most of the skin is reddened and any amount of the skin surface is covered with <GlossaryTermRef href="CDR0000729587">patches</GlossaryTermRef>, <GlossaryTermRef href="CDR0000729589">papules</GlossaryTermRef>, <GlossaryTermRef href="CDR0000439411">plaques</GlossaryTermRef>,  or <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef>. Cancer has spread to other <GlossaryTermRef href="CDR0000257523">organs</GlossaryTermRef> in the body. <GlossaryTermRef href="CDR0000045762">Lymph nodes</GlossaryTermRef> may be enlarged  and cancer  may have spread to them. There may be cancerous <GlossaryTermRef href="CDR0000045765">lymphocytes</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef>.</ListItem> 
		  </ItemizedList></SummarySection><SummarySection id="_175"><KeyPoint id="_176">Stage IV Sézary Syndrome</KeyPoint><Para id="_177">In <GlossaryTermRef href="CDR0000752262">stage IV</GlossaryTermRef>:</Para><ItemizedList id="_178" Style="bullet">
     <ListItem>Most of the skin is reddened and covered with patches, <GlossaryTermRef href="CDR0000729589">papules</GlossaryTermRef>, <GlossaryTermRef href="CDR0000439412">plaques</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000046634">tumors</GlossaryTermRef>; and</ListItem><ListItem>There is a high level of cancerous <GlossaryTermRef href="CDR0000045765">lymphocytes</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef>; and</ListItem><ListItem><GlossaryTermRef href="CDR0000045762">Lymph nodes</GlossaryTermRef> may be enlarged and <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> may have spread to them.</ListItem></ItemizedList></SummarySection></SummarySection></SummarySection><SummarySection id="_48"><SectMetaData><SectionType>Classification by stage</SectionType></SectMetaData><Title>Recurrent Mycosis Fungoides and the Sézary Syndrome</Title><Para id="_49"><GlossaryTermRef href="CDR0000045861">Recurrent</GlossaryTermRef>
		<GlossaryTermRef href="CDR0000045794">mycosis fungoides</GlossaryTermRef> and the
		<GlossaryTermRef href="CDR0000045878">Sézary syndrome</GlossaryTermRef> are
		<GlossaryTermRef href="CDR0000045333">cancers</GlossaryTermRef> that have <GlossaryTermRef href="CDR0000046556">recurred</GlossaryTermRef> (come back)
		after they have been treated. The cancer may come back in the skin or in other parts of the body.</Para></SummarySection><SummarySection id="_50"><Title>Treatment Option Overview</Title><SummarySection id="_51"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><KeyPoint id="_52">There are different types of treatment for patients with
		  mycosis fungoides and the Sézary syndrome cancer. </KeyPoint><Para id="_53">Different types of treatment are available for patients with
		  <GlossaryTermRef href="CDR0000045794">mycosis fungoides</GlossaryTermRef> and the
		  <GlossaryTermRef href="CDR0000045878">Sézary syndrome</GlossaryTermRef>. Some treatments are
		  <GlossaryTermRef href="CDR0000044930">standard</GlossaryTermRef> (the currently used treatment), and some are being tested in
		  <GlossaryTermRef href="CDR0000045961">clinical trials</GlossaryTermRef>. A
		  treatment clinical trial is a <GlossaryTermRef href="CDR0000651211">research study</GlossaryTermRef> meant to help improve current
		  treatments or obtain information on new treatments for patients with
		  <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef>. When clinical trials show that
		  a new treatment is better than the standard
		  treatment, the new treatment may become the standard treatment.       Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.

		  </Para></SummarySection><SummarySection id="_55"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><KeyPoint id="_56">Six types of standard treatment are used:</KeyPoint><SummarySection id="_57"><KeyPoint id="_58">Photodynamic therapy
			 </KeyPoint><Para id="_120"><GlossaryTermRef href="CDR0000045238">Photodynamic therapy</GlossaryTermRef> is a cancer treatment that uses a <GlossaryTermRef href="CDR0000348921">drug</GlossaryTermRef> and a certain type of <GlossaryTermRef href="CDR0000045748">laser</GlossaryTermRef> light to kill cancer <GlossaryTermRef href="CDR0000046476">cells</GlossaryTermRef>. A drug that is not active until it is exposed to light is <GlossaryTermRef href="CDR0000044678">injected</GlossaryTermRef> into a <GlossaryTermRef href="CDR0000476471">vein</GlossaryTermRef>. The drug collects more in cancer cells than in normal cells. For <GlossaryTermRef href="CDR0000445084">skin cancer</GlossaryTermRef>, laser light is shined onto the skin and the drug becomes active and kills the cancer cells. Photodynamic therapy causes little damage to healthy <GlossaryTermRef href="CDR0000046683">tissue</GlossaryTermRef>.  Patients undergoing photodynamic therapy will need to limit  the amount of time spent in sunlight. </Para><Para id="_133">In one
			 type of photodynamic therapy, called <GlossaryTermRef href="CDR0000439423">psoralen and ultraviolet A (PUVA) therapy</GlossaryTermRef>, the  patient receives a drug
			 called <GlossaryTermRef href="CDR0000044900">psoralen</GlossaryTermRef> and then
			 <GlossaryTermRef href="CDR0000046700">ultraviolet radiation</GlossaryTermRef> is directed to
			 the skin. In another type of photodynamic therapy, called <GlossaryTermRef href="CDR0000403135">extracorporeal photochemotherapy</GlossaryTermRef>, the patient is given drugs and then some <GlossaryTermRef href="CDR0000270735">blood</GlossaryTermRef> cells are
			 taken from the body, put under a special <GlossaryTermRef href="CDR0000046700">ultraviolet A light</GlossaryTermRef>, and put back into the body. </Para></SummarySection><SummarySection id="_60"><KeyPoint id="_61">Radiation therapy
			 </KeyPoint><Para id="_110"><GlossaryTermRef href="CDR0000044971">Radiation therapy</GlossaryTermRef> is a cancer treatment that uses high-energy <GlossaryTermRef href="CDR0000045944">x-rays</GlossaryTermRef> or other types of <GlossaryTermRef href="CDR0000045072">radiation</GlossaryTermRef> to kill cancer cells or keep them from growing. There are two types of radiation therapy.  <GlossaryTermRef href="CDR0000046686">External radiation therapy</GlossaryTermRef> uses a machine outside the body to send radiation toward the cancer.  <GlossaryTermRef href="CDR0000046345">Internal radiation therapy</GlossaryTermRef> uses a <GlossaryTermRef href="CDR0000046550">radioactive</GlossaryTermRef> substance sealed in needles, <GlossaryTermRef href="CDR0000257219">seeds</GlossaryTermRef>, wires, or <GlossaryTermRef href="CDR0000045637">catheters</GlossaryTermRef> that are placed directly into or near the cancer.</Para><Para id="_128">Sometimes, <GlossaryTermRef href="CDR0000439430">total skin electron beam (TSEB) radiation therapy</GlossaryTermRef> is used to treat mycosis fungoides and the Sézary syndrome.  This is a type of radiation treatment in which  the skin over the whole body is treated with rays of tiny particles called electrons.</Para><Para id="_129">The way the radiation therapy is given depends on the type and <GlossaryTermRef href="CDR0000045885">stage</GlossaryTermRef> of the cancer being treated.</Para></SummarySection><SummarySection id="_63"><KeyPoint id="_64">Chemotherapy </KeyPoint><Para id="_111"><GlossaryTermRef href="CDR0000045214">Chemotherapy</GlossaryTermRef> is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.   When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (<GlossaryTermRef href="CDR0000301626">systemic chemotherapy</GlossaryTermRef>). When chemotherapy is placed directly into the <GlossaryTermRef href="CDR0000046483">cerebrospinal fluid</GlossaryTermRef>, an <GlossaryTermRef href="CDR0000257523">organ</GlossaryTermRef>, or a body <GlossaryTermRef href="CDR0000463703">cavity</GlossaryTermRef> such as the <GlossaryTermRef href="CDR0000045070">abdomen</GlossaryTermRef>, the drugs mainly affect cancer cells in those areas (<GlossaryTermRef href="CDR0000046559">regional chemotherapy</GlossaryTermRef>).  Sometimes the chemotherapy is <GlossaryTermRef href="CDR0000045927">topical</GlossaryTermRef>
			 (put on the skin in a cream, lotion, or <GlossaryTermRef href="CDR0000508685">ointment</GlossaryTermRef>). The way the chemotherapy is given depends on the type and stage of the cancer being treated.</Para><Para id="_165">See <ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/drugs/non-hodgkin">Drugs Approved for Non-Hodgkin Lymphoma</ExternalRef> for more information. (Mycosis fungoides and the Sézary syndrome are types of <GlossaryTermRef href="CDR0000045148">non-Hodgkin lymphoma</GlossaryTermRef>.)</Para></SummarySection><SummarySection id="_134"><KeyPoint id="_68">Other drug therapy</KeyPoint><Para id="_137"> Topical <GlossaryTermRef href="CDR0000045658">corticosteroids</GlossaryTermRef> are used to relieve red, swollen, and <GlossaryTermRef href="CDR0000044042">inflamed</GlossaryTermRef> skin. They are a type of <GlossaryTermRef href="CDR0000613764">steroid</GlossaryTermRef>. Topical corticosteroids  may be in a cream, lotion, or ointment.</Para><Para id="_112"><GlossaryTermRef href="CDR0000045870">Retinoids</GlossaryTermRef>, such as <GlossaryTermRef href="CDR0000045423">bexarotene</GlossaryTermRef>, are drugs related to <GlossaryTermRef href="CDR0000045248">vitamin A</GlossaryTermRef> that can slow the growth of certain types of cancer cells. The retinoids may be taken by mouth or put on the skin.</Para><Para id="_169">See <ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/drugs/non-hodgkin">Drugs Approved for Non-Hodgkin Lymphoma</ExternalRef> for more information. (Mycosis fungoides and the Sézary syndrome are types of non-Hodgkin lymphoma.)</Para></SummarySection><SummarySection id="_135"><KeyPoint id="_132">Biologic therapy</KeyPoint><Para id="_131"><GlossaryTermRef href="CDR0000045617">Biologic therapy</GlossaryTermRef> is a treatment that uses the patient's <GlossaryTermRef href="CDR0000046356">immune system</GlossaryTermRef> to fight cancer.  Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer.  This type of cancer treatment is also called biotherapy or immunotherapy.</Para><Para id="_70"><GlossaryTermRef href="CDR0000045324">Interferon</GlossaryTermRef> is a type of biologic therapy used to treat mycosis
			 fungoides and the Sézary syndrome. It interferes with the division of cancer cells and can slow
				<GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> growth.</Para><Para id="_166">See <ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/drugs/non-hodgkin">Drugs Approved for Non-Hodgkin Lymphoma</ExternalRef> for more information. (Mycosis fungoides and the Sézary syndrome are types of non-Hodgkin lymphoma.)</Para></SummarySection><SummarySection id="_154"><KeyPoint id="_155">Targeted therapy</KeyPoint><Para id="_156"><GlossaryTermRef href="CDR0000270742">Targeted therapy</GlossaryTermRef> is a treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. <GlossaryTermRef href="CDR0000046066">Monoclonal antibody</GlossaryTermRef> therapy and other types of targeted therapies are used to treat mycosis fungoides and the Sézary syndrome.</Para><Para id="_157"><GlossaryTermRef href="CDR0000044851">Alemtuzumab</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045454">denileukin diftitox</GlossaryTermRef> are monoclonal antibodies used to treat mycosis fungoides and the Sézary syndrome. Monoclonal antibody therapy uses <GlossaryTermRef href="CDR0000044918">antibodies</GlossaryTermRef> made in the laboratory, from a single type of <GlossaryTermRef href="CDR0000046356">immune system</GlossaryTermRef> cell. These antibodies can identify substances on cancer cells or normal substances that may help cancer cells grow.  The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by <GlossaryTermRef href="CDR0000045738">infusion</GlossaryTermRef>. They may be used alone or to carry drugs, <GlossaryTermRef href="CDR0000046622">toxins</GlossaryTermRef>, or radioactive material directly to cancer cells. </Para><Para id="_170"><GlossaryTermRef href="CDR0000455153">Vorinostat</GlossaryTermRef> and <GlossaryTermRef href="CDR0000509038">romidepsin</GlossaryTermRef> are two of the <GlossaryTermRef href="CDR0000472896">histone deacetylase (HDAC) inhibitors</GlossaryTermRef> used to treat mycosis fungoides and the Sézary syndrome. HDAC inhibitors cause a chemical change that stops tumor cells from dividing.</Para><Para id="_174"><GlossaryTermRef href="CDR0000657510">Pralatrexate</GlossaryTermRef> is a <GlossaryTermRef href="CDR0000754028">dihydrofolate reductase (DHFR) inhibitor</GlossaryTermRef>  used to treat mycosis fungoides and the  Sézary syndrome. It builds up in cancer cells  and stops  them from using <GlossaryTermRef href="CDR0000046764">folate</GlossaryTermRef>, a <GlossaryTermRef href="CDR0000044697">nutrient</GlossaryTermRef>  needed for cells to divide. Pralatrexate may slow the growth of tumors and kill cancer cells.
</Para><Para id="_167">See <ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/drugs/non-hodgkin">Drugs Approved for Non-Hodgkin Lymphoma</ExternalRef> for more information. (Mycosis fungoides and the Sézary syndrome are types of non-Hodgkin lymphoma.)</Para></SummarySection></SummarySection><SummarySection id="_72"><SectMetaData><SectionType>Treatment in clinical trials</SectionType></SectMetaData><KeyPoint id="_73">New types of treatment are being tested in clinical
		  trials. </KeyPoint><Para id="_144">This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the    <ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/clinical-trials">NCI Web site</ExternalRef>.</Para><SummarySection id="_159"><KeyPoint id="_160">Ultraviolet B radiation therapy </KeyPoint><Para id="_136"><GlossaryTermRef href="CDR0000046700">Ultraviolet B (UVB) radiation therapy</GlossaryTermRef> uses a special lamp or laser that directs <GlossaryTermRef href="CDR0000269473">UVB radiation</GlossaryTermRef> at the skin. </Para></SummarySection><SummarySection id="_74"><KeyPoint id="_75">High-dose chemotherapy and radiation therapy with stem cell transplant</KeyPoint><Para id="_96">This treatment is a method of giving high <GlossaryTermRef href="CDR0000044664">doses</GlossaryTermRef> of chemotherapy and radiation therapy and replacing blood-forming cells destroyed by the cancer treatment. <GlossaryTermRef href="CDR0000046598">Stem cells</GlossaryTermRef> (immature blood cells) are removed from the <GlossaryTermRef href="CDR0000045622">bone marrow</GlossaryTermRef> or blood of the patient or a <GlossaryTermRef href="CDR0000643010">donor</GlossaryTermRef> and are frozen and stored. After <GlossaryTermRef href="CDR0000044737">therapy</GlossaryTermRef> is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.</Para></SummarySection></SummarySection><SummarySection id="_148"><KeyPoint id="_149">Patients may want to think about taking part in a clinical trial.</KeyPoint><Para id="_148_23">For some patients, taking part in a <GlossaryTermRef href="CDR0000045961">clinical trial</GlossaryTermRef> may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer  treatments are safe and effective or better than the <GlossaryTermRef href="CDR0000044930">standard treatment</GlossaryTermRef>.</Para><Para id="_148_24">Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first  to receive a new treatment.</Para><Para id="_148_25">Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.</Para></SummarySection><SummarySection id="_150"><KeyPoint id="_151">Patients can enter clinical trials before, during, or after starting their cancer treatment.</KeyPoint><Para id="_150_29">Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from <GlossaryTermRef href="CDR0000046556">recurring</GlossaryTermRef> (coming back) or reduce the <GlossaryTermRef href="CDR0000046580">side effects</GlossaryTermRef> of cancer treatment.</Para><Para id="_150_30">Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from <GlossaryTermRef href="CDR0000044267">NCI's</GlossaryTermRef> listing of clinical trials. </Para></SummarySection><SummarySection id="_152"><KeyPoint id="_153">Follow-up tests may be needed.</KeyPoint><Para id="_152_33">Some of the tests that were done to <GlossaryTermRef href="CDR0000046450">diagnose</GlossaryTermRef> the cancer or to find out the <GlossaryTermRef href="CDR0000045885">stage</GlossaryTermRef> of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.</Para><Para id="_152_34">Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your <GlossaryTermRef href="CDR0000651193">condition</GlossaryTermRef> has changed or if the cancer has <GlossaryTermRef href="CDR0000046556">recurred</GlossaryTermRef> (come back). These tests are sometimes called <GlossaryTermRef href="CDR0000044671">follow-up</GlossaryTermRef> tests or check-ups.</Para></SummarySection></SummarySection><SummarySection id="_79"><SectMetaData><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Treatment Options by Stage </Title><SummarySection id="_80"><SectMetaData><SpecificDiagnosis ref="CDR0000038224">stage I mycosis fungoides/Sezary syndrome</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Stage I Mycosis Fungoides</Title><Para id="_81">Treatment of  <GlossaryTermRef href="CDR0000454834">stage I mycosis fungoides</GlossaryTermRef> may include the following:</Para><ItemizedList id="_82" Style="bullet"> 
		  <ListItem><GlossaryTermRef href="CDR0000439424">PUVA
			 therapy</GlossaryTermRef> with or without <GlossaryTermRef href="CDR0000045617">biologic therapy</GlossaryTermRef>   (<GlossaryTermRef href="CDR0000045324">interferon</GlossaryTermRef>).</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000044971">Radiation therapy</GlossaryTermRef>
			 to a single skin <GlossaryTermRef href="CDR0000046324">lesion</GlossaryTermRef> or to all the skin on the body (<GlossaryTermRef href="CDR0000439431">TSEB</GlossaryTermRef>).</ListItem> 
		   
		  <ListItem><GlossaryTermRef href="CDR0000045927">Topical</GlossaryTermRef> <GlossaryTermRef href="CDR0000045658">corticosteroid</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737">therapy</GlossaryTermRef>.</ListItem><ListItem>Radiation therapy to skin lesions, as
			 <GlossaryTermRef href="CDR0000045815">palliative therapy</GlossaryTermRef> to reduce
			 <GlossaryTermRef href="CDR0000046634">tumor</GlossaryTermRef> size or relieve
			 <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> and improve
			 <GlossaryTermRef href="CDR0000045417">quality of life</GlossaryTermRef>.</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000046619">Topical
			 chemotherapy</GlossaryTermRef>.</ListItem><ListItem>Biologic therapy (interferon) with or without topical
			 chemotherapy.</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000045870">Retinoid</GlossaryTermRef> therapy. </ListItem><ListItem><GlossaryTermRef href="CDR0000301626">Systemic chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742">Targeted therapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000455153">vorinostat</GlossaryTermRef>, <GlossaryTermRef href="CDR0000509038">romidepsin</GlossaryTermRef>, or other <GlossaryTermRef href="CDR0000472896">histone deacetylase (HDAC) inhibitors</GlossaryTermRef>.</ListItem><ListItem>Targeted therapy with <GlossaryTermRef href="CDR0000657510">pralatrexate</GlossaryTermRef>.</ListItem><ListItem>Targeted therapy with a <GlossaryTermRef href="CDR0000046066">monoclonal antibody</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045454">denileukin diftitox</GlossaryTermRef>).</ListItem> 
		<ListItem>A <GlossaryTermRef href="CDR0000045961">clinical trial</GlossaryTermRef> of <GlossaryTermRef href="CDR0000046700">ultraviolet B (UVB) radiation therapy</GlossaryTermRef>. </ListItem><ListItem>A clinical trial of a new treatment.</ListItem></ItemizedList><Para id="_TrialSearch_80_10">Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with <ExternalRef xref="http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?Diagnosis=38224&amp;tt=1&amp;format=1&amp;cn=1">stage I mycosis fungoides/Sezary syndrome</ExternalRef>. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug.  Talk with your doctor about clinical trials that may be right for you.  General information about clinical trials is available from the <ExternalRef xref="http://www.cancer.gov/clinicaltrials">NCI Web site</ExternalRef>.</Para></SummarySection><SummarySection id="_83"><SectMetaData><SpecificDiagnosis ref="CDR0000038225">stage II mycosis fungoides/Sezary syndrome</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Stage II Mycosis Fungoides</Title><Para id="_84">Treatment of <GlossaryTermRef href="CDR0000454837">stage II mycosis fungoides</GlossaryTermRef> is <GlossaryTermRef href="CDR0000045815">palliative</GlossaryTermRef> (to relieve <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> and improve the <GlossaryTermRef href="CDR0000045417">quality of life</GlossaryTermRef>)  and may
		  include the following:</Para><ItemizedList id="_85" Style="bullet"> 
		  <ListItem><GlossaryTermRef href="CDR0000439424">PUVA therapy</GlossaryTermRef> with or without <GlossaryTermRef href="CDR0000045617">biologic therapy</GlossaryTermRef>  (<GlossaryTermRef href="CDR0000045324">interferon</GlossaryTermRef>).</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000044971">Radiation therapy</GlossaryTermRef> to all the skin on the body (<GlossaryTermRef href="CDR0000439431">TSEB</GlossaryTermRef>). </ListItem> 
		   
		  <ListItem><GlossaryTermRef href="CDR0000045927">Topical</GlossaryTermRef> <GlossaryTermRef href="CDR0000045658">corticosteroid</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737">therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046619">Topical chemotherapy</GlossaryTermRef>.</ListItem><ListItem>Radiation therapy to skin <GlossaryTermRef href="CDR0000046324">lesions</GlossaryTermRef>.</ListItem> 
		  <ListItem>Biologic therapy  (interferon) with or without topical
			 chemotherapy.</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000045870">Retinoid</GlossaryTermRef> therapy.</ListItem><ListItem><GlossaryTermRef href="CDR0000689103">Oral chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000301626">Systemic chemotherapy</GlossaryTermRef>.</ListItem> 
		<ListItem><GlossaryTermRef href="CDR0000270742">Targeted therapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000455153">vorinostat</GlossaryTermRef>, <GlossaryTermRef href="CDR0000509038">romidepsin</GlossaryTermRef>, or other <GlossaryTermRef href="CDR0000472896">histone deacetylase (HDAC) inhibitors</GlossaryTermRef>.</ListItem><ListItem>Targeted therapy with <GlossaryTermRef href="CDR0000657510">pralatrexate</GlossaryTermRef>.</ListItem><ListItem>Targeted therapy with a <GlossaryTermRef href="CDR0000046066">monoclonal antibody</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045454">denileukin diftitox</GlossaryTermRef>).</ListItem> 
		<ListItem>A <GlossaryTermRef href="CDR0000045961">clinical trial</GlossaryTermRef> of <GlossaryTermRef href="CDR0000046700">ultraviolet B (UVB) radiation therapy</GlossaryTermRef>. </ListItem><ListItem>A clinical trial of a new treatment.</ListItem></ItemizedList><Para id="_TrialSearch_83_10">Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with <ExternalRef xref="http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?Diagnosis=38225&amp;tt=1&amp;format=1&amp;cn=1">stage II mycosis fungoides/Sezary syndrome</ExternalRef>. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug.  Talk with your doctor about clinical trials that may be right for you.  General information about clinical trials is available from the <ExternalRef xref="http://www.cancer.gov/clinicaltrials">NCI Web site</ExternalRef>.</Para></SummarySection><SummarySection id="_86"><SectMetaData><SpecificDiagnosis ref="CDR0000038226">stage III mycosis fungoides/Sezary syndrome</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Stage III Mycosis Fungoides</Title><Para id="_87">Treatment of <GlossaryTermRef href="CDR0000454840">stage III mycosis fungoides</GlossaryTermRef>
		  is <GlossaryTermRef href="CDR0000045815">palliative</GlossaryTermRef> (to relieve <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> and improve the <GlossaryTermRef href="CDR0000045417">quality of life</GlossaryTermRef>)  and may include the following:</Para><ItemizedList id="_88" Style="bullet"> 
		  <ListItem><GlossaryTermRef href="CDR0000439424">PUVA therapy</GlossaryTermRef> with or without <GlossaryTermRef href="CDR0000301626">systemic chemotherapy</GlossaryTermRef>.</ListItem><ListItem>PUVA therapy with or without <GlossaryTermRef href="CDR0000045617">biologic therapy</GlossaryTermRef>  (<GlossaryTermRef href="CDR0000045324">interferon</GlossaryTermRef>).</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000044971">Radiation therapy</GlossaryTermRef> to all the skin on the body (<GlossaryTermRef href="CDR0000439431">TSEB</GlossaryTermRef>). </ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000045927">Topical</GlossaryTermRef> <GlossaryTermRef href="CDR0000045658">corticosteroid</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737">therapy</GlossaryTermRef>.</ListItem><ListItem>Radiation therapy to skin <GlossaryTermRef href="CDR0000046324">lesions</GlossaryTermRef>.</ListItem> 
		  <ListItem>Systemic chemotherapy with one or more <GlossaryTermRef href="CDR0000348921">drugs</GlossaryTermRef>,
			 with or without <GlossaryTermRef href="CDR0000046619">topical chemotherapy</GlossaryTermRef>.</ListItem> 
		  <ListItem> Biologic therapy (interferon) with or without topical chemotherapy.</ListItem> 
		   
		   
		  <ListItem><GlossaryTermRef href="CDR0000403135">Extracorporeal photochemotherapy</GlossaryTermRef>.</ListItem><ListItem>Topical chemotherapy.</ListItem><ListItem><GlossaryTermRef href="CDR0000045870">Retinoid</GlossaryTermRef> therapy. </ListItem> 
		<ListItem><GlossaryTermRef href="CDR0000689103">Oral chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742">Targeted therapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000455153">vorinostat</GlossaryTermRef>, <GlossaryTermRef href="CDR0000509038">romidepsin</GlossaryTermRef>, or other <GlossaryTermRef href="CDR0000472896">histone deacetylase (HDAC) inhibitors</GlossaryTermRef>.</ListItem><ListItem>Targeted therapy with <GlossaryTermRef href="CDR0000657510">pralatrexate</GlossaryTermRef>.</ListItem><ListItem>Targeted therapy with a <GlossaryTermRef href="CDR0000046066">monoclonal antibody</GlossaryTermRef> (<GlossaryTermRef href="CDR0000044851">alemtuzumab</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045454">denileukin diftitox</GlossaryTermRef>).</ListItem><ListItem>A <GlossaryTermRef href="CDR0000045961">clinical trial</GlossaryTermRef> of <GlossaryTermRef href="CDR0000046700">ultraviolet B (UVB) radiation therapy</GlossaryTermRef>. </ListItem><ListItem>A clinical trial of a new treatment.</ListItem></ItemizedList><Para id="_TrialSearch_86_10">Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with <ExternalRef xref="http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?Diagnosis=38226&amp;tt=1&amp;format=1&amp;cn=1">stage III mycosis fungoides/Sezary syndrome</ExternalRef>. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug.  Talk with your doctor about clinical trials that may be right for you.  General information about clinical trials is available from the <ExternalRef xref="http://www.cancer.gov/clinicaltrials">NCI Web site</ExternalRef>.</Para></SummarySection><SummarySection id="_89"><SectMetaData><SpecificDiagnosis ref="CDR0000038227">stage IV mycosis fungoides/Sezary syndrome</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Stage IV Mycosis Fungoides and the Sézary Syndrome</Title><Para id="_90">Treatment of <GlossaryTermRef href="CDR0000454841">stage IV mycosis fungoides</GlossaryTermRef> and <GlossaryTermRef href="CDR0000752262">stage IV Sézary syndrome</GlossaryTermRef> is <GlossaryTermRef href="CDR0000045815">palliative</GlossaryTermRef>  (to relieve <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> and improve the <GlossaryTermRef href="CDR0000045417">quality of life</GlossaryTermRef>)  and may
		  include the following:</Para><ItemizedList id="_91" Style="bullet"> 
		  <ListItem><GlossaryTermRef href="CDR0000439424">PUVA therapy</GlossaryTermRef> with or without <GlossaryTermRef href="CDR0000301626">systemic chemotherapy</GlossaryTermRef>.</ListItem><ListItem>PUVA therapy with or without <GlossaryTermRef href="CDR0000045617">biologic therapy</GlossaryTermRef>  (<GlossaryTermRef href="CDR0000045324">interferon</GlossaryTermRef>).</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000044971">Radiation therapy</GlossaryTermRef> to all the skin on the body (<GlossaryTermRef href="CDR0000439431">TSEB</GlossaryTermRef>), with or without systemic chemotherapy. </ListItem><ListItem><GlossaryTermRef href="CDR0000045927">Topical</GlossaryTermRef> <GlossaryTermRef href="CDR0000045658">corticosteroid</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737">therapy</GlossaryTermRef>.</ListItem> 
		  <ListItem>Radiation therapy to skin <GlossaryTermRef href="CDR0000046324">lesions</GlossaryTermRef>.</ListItem> 
		  <ListItem>Systemic chemotherapy with one or more <GlossaryTermRef href="CDR0000348921">drugs</GlossaryTermRef>.</ListItem> 
		  <ListItem>Biologic therapy (interferon) with or without <GlossaryTermRef href="CDR0000046619">topical chemotherapy</GlossaryTermRef>.</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000270742">Targeted therapy</GlossaryTermRef> with a <GlossaryTermRef href="CDR0000046066">monoclonal antibody</GlossaryTermRef> (<GlossaryTermRef href="CDR0000044851">alemtuzumab</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045454">denileukin diftitox</GlossaryTermRef>).</ListItem><ListItem>Topical chemotherapy.</ListItem> 
		   
		  <ListItem><GlossaryTermRef href="CDR0000403135">Extracorporeal photochemotherapy</GlossaryTermRef> with or without radiation
			 therapy to all the skin on the body.</ListItem> 
		  <ListItem><GlossaryTermRef href="CDR0000045870">Retinoid</GlossaryTermRef> therapy.</ListItem> 
		<ListItem><GlossaryTermRef href="CDR0000689103">Oral chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742">Targeted therapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000455153">vorinostat</GlossaryTermRef>, <GlossaryTermRef href="CDR0000509038">romidepsin</GlossaryTermRef>, or other <GlossaryTermRef href="CDR0000472896">histone deacetylase (HDAC) inhibitors</GlossaryTermRef>.</ListItem><ListItem>Targeted therapy with <GlossaryTermRef href="CDR0000657510">pralatrexate</GlossaryTermRef>.</ListItem><ListItem>A <GlossaryTermRef href="CDR0000045961">clinical trial</GlossaryTermRef> of <GlossaryTermRef href="CDR0000046700">ultraviolet B (UVB) radiation therapy</GlossaryTermRef>. </ListItem><ListItem>A clinical trial of a new treatment.</ListItem></ItemizedList><Para id="_TrialSearch_89_10">Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with <ExternalRef xref="http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?Diagnosis=38227&amp;tt=1&amp;format=1&amp;cn=1">stage IV mycosis fungoides/Sezary syndrome</ExternalRef>. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug.  Talk with your doctor about clinical trials that may be right for you.  General information about clinical trials is available from the <ExternalRef xref="http://www.cancer.gov/clinicaltrials">NCI Web site</ExternalRef>.</Para></SummarySection></SummarySection><SummarySection id="_92"><SectMetaData><SpecificDiagnosis ref="CDR0000038228">recurrent mycosis fungoides/Sezary syndrome</SpecificDiagnosis><SectionType>Treatment options for recurrent cancer</SectionType></SectMetaData><Title>Treatment Options for Recurrent Mycosis Fungoides and the Sézary
		Syndrome</Title><Para id="_93">Treatment of <GlossaryTermRef href="CDR0000045862">recurrent</GlossaryTermRef>
		<GlossaryTermRef href="CDR0000045794">mycosis fungoides</GlossaryTermRef> and the <GlossaryTermRef href="CDR0000045878">Sézary syndrome</GlossaryTermRef> is usually within a <GlossaryTermRef href="CDR0000045961">clinical trial</GlossaryTermRef> and may include the
		following:</Para><ItemizedList id="_94" Style="bullet"> 
		<ListItem> <GlossaryTermRef href="CDR0000044971">Radiation
		  therapy</GlossaryTermRef> to skin <GlossaryTermRef href="CDR0000046324">lesions</GlossaryTermRef> or all the skin on the body (<GlossaryTermRef href="CDR0000439431">TSEB</GlossaryTermRef>).</ListItem> 
		<ListItem><GlossaryTermRef href="CDR0000046619">Topical chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000439424">PUVA therapy</GlossaryTermRef>,  to relieve <GlossaryTermRef href="CDR0000045022">symptoms</GlossaryTermRef> and improve the <GlossaryTermRef href="CDR0000045417">quality of life</GlossaryTermRef>.</ListItem> 
		<ListItem>PUVA therapy with <GlossaryTermRef href="CDR0000045617">biologic therapy</GlossaryTermRef> (<GlossaryTermRef href="CDR0000045324">interferon</GlossaryTermRef>).</ListItem> 
		<ListItem><GlossaryTermRef href="CDR0000046700">Ultraviolet B (UVB) radiation therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045927">Topical</GlossaryTermRef> <GlossaryTermRef href="CDR0000045658">corticosteroid</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737">therapy</GlossaryTermRef>, to relieve symptoms and improve the quality of life.</ListItem><ListItem><GlossaryTermRef href="CDR0000403135">Extracorporeal photochemotherapy</GlossaryTermRef>.</ListItem> 
		<ListItem><GlossaryTermRef href="CDR0000270742">Targeted therapy</GlossaryTermRef> with a <GlossaryTermRef href="CDR0000045857">radiolabeled</GlossaryTermRef> <GlossaryTermRef href="CDR0000046066">monoclonal antibody</GlossaryTermRef>.</ListItem> 
		<ListItem>Targeted therapy with a monoclonal antibody (<GlossaryTermRef href="CDR0000044851">alemtuzumab</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045454">denileukin diftitox</GlossaryTermRef>).</ListItem> 
		 
		<ListItem><GlossaryTermRef href="CDR0000045870">Retinoid</GlossaryTermRef> therapy.</ListItem><ListItem><GlossaryTermRef href="CDR0000045214">Chemotherapy</GlossaryTermRef>.</ListItem> 
		<ListItem><GlossaryTermRef href="CDR0000346522">High-dose chemotherapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000046695">stem cell transplant</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742">Targeted therapy</GlossaryTermRef> with <GlossaryTermRef href="CDR0000455153">vorinostat</GlossaryTermRef>, <GlossaryTermRef href="CDR0000509038">romidepsin</GlossaryTermRef>, or other <GlossaryTermRef href="CDR0000472896">histone deacetylase (HDAC) inhibitors</GlossaryTermRef>.</ListItem><ListItem>Targeted therapy with <GlossaryTermRef href="CDR0000657510">pralatrexate</GlossaryTermRef>.</ListItem> 
	 </ItemizedList><Para id="_TrialSearch_92_10">Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with <ExternalRef xref="http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?Diagnosis=38228&amp;tt=1&amp;format=1&amp;cn=1">recurrent mycosis fungoides/Sezary syndrome</ExternalRef>. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug.  Talk with your doctor about clinical trials that may be right for you.  General information about clinical trials is available from the <ExternalRef xref="http://www.cancer.gov/clinicaltrials">NCI Web site</ExternalRef>.</Para></SummarySection><SummarySection id="_141"><Title>To Learn More About Mycosis Fungoides and the Sézary Syndrome</Title><Para id="_138">For more information from the <GlossaryTermRef href="CDR0000044266">National Cancer Institute</GlossaryTermRef> about  mycosis fungoides and the Sézary syndrome, see the following:</Para><ItemizedList id="_168" Style="bullet"><ListItem><ExternalRef xref="http://www.cancer.gov/types/lymphoma">Lymphoma  Home Page</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/types/surgery/photodynamic-fact-sheet">Photodynamic Therapy for Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/drugs/non-hodgkin">Drugs Approved for Non-Hodgkin Lymphoma</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/types/immunotherapy/bio-therapies-fact-sheet">Biological Therapies for Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet">Targeted Cancer Therapies</ExternalRef></ListItem></ItemizedList><Para id="_141_40">For general <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> information and other resources from the National Cancer Institute, see the following:</Para><ItemizedList id="_141_41" Style="bullet"><ListItem><ExternalRef xref="http://www.cancer.gov/cancertopics/factsheet/Detection/staging">Cancer Staging</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/publications/patient-education/chemo-and-you">Chemotherapy and You: Support for People With Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/publications/patient-education/radiation-therapy-and-you">Radiation Therapy and You: Support for People With Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/cancertopics/coping">Coping with Cancer: Supportive and Palliative Care</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/cancertopics/cancerlibrary/questions">Questions to Ask Your Doctor About Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="http://www.cancer.gov/cancertopics/cancerlibrary">Cancer Library</ExternalRef>
</ListItem><ListItem><ExternalRef xref="http://cancercontrol.cancer.gov/ocs/resources/survivors.html">For Survivors and Caregivers</ExternalRef>
</ListItem></ItemizedList></SummarySection><SummarySection id="_100"><SectMetaData><SectionType>Changes to summary</SectionType></SectMetaData><Title>Changes to This Summary (05/26/2015)</Title><Para id="_101">The <GlossaryTermRef href="CDR0000044271">PDQ</GlossaryTermRef> <GlossaryTermRef href="CDR0000045333">cancer</GlossaryTermRef> information summaries are reviewed regularly and updated as new information becomes available.  This section describes the latest changes made to this summary as of the date above.</Para><Para id="_171">Editorial changes were made to this summary.</Para></SummarySection><SummarySection id="_AboutThis_1"><Title>About This PDQ Summary</Title><SummarySection id="_AboutThis_2"><Title>About PDQ</Title><Para id="_AboutThis_3">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <ExternalRef xref="http://www.cancer.gov/espanol/recursos/pdq">Spanish</ExternalRef>.</Para><Para id="_AboutThis_4">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government’s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</Para></SummarySection><SummarySection id="_AboutThis_5"><Title>Purpose of This Summary</Title><Para id="_AboutThis_6">This PDQ cancer information summary has current information about the treatment of mycosis fungoides and the Sézary Syndrome.  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para></SummarySection><SummarySection id="_AboutThis_7"><Title>Reviewers and Updates</Title><Para id="_AboutThis_8">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Date Last Modified") is the date of the most recent change.
</Para><Para id="_AboutThis_9">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <ExternalRef xref="http://www.cancer.gov/cancertopics/pdq/adult-treatment-board">PDQ Adult Treatment Editorial Board</ExternalRef>.
</Para></SummarySection><SummarySection id="_AboutThis_10"><Title>Clinical Trial Information</Title><Para id="_AboutThis_11">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
</Para><Para id="_AboutThis_12">Clinical trials are listed in PDQ and can be found online at <ExternalRef xref="http://www.cancer.gov/clinicaltrials">NCI's Web site</ExternalRef>. Many cancer doctors who take part in clinical trials are also listed in PDQ. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237).
</Para></SummarySection><SummarySection id="_AboutThis_13"><Title>Permission to Use This Summary</Title><Para id="_AboutThis_14">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as “NCI’s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].”
</Para><Para id="_AboutThis_15">The best way to cite this PDQ summary is:</Para><Para id="_AboutThis_21">National Cancer Institute: PDQ® Mycosis Fungoides and the Sézary Syndrome Treatment. Bethesda, MD: National Cancer Institute. Date last modified  &lt;MM/DD/YYYY&gt;. Available at: <ExternalRef xref="http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq">http://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq</ExternalRef>.  Accessed &lt;MM/DD/YYYY&gt;.</Para><Para id="_AboutThis_16">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <ExternalRef xref="http://visualsonline.cancer.gov/">Visuals Online</ExternalRef>. Visuals Online is a collection of more than 2,000 scientific images.
</Para></SummarySection><SummarySection id="_AboutThis_17"><Title>Disclaimer</Title><Para id="_AboutThis_18">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <ExternalRef xref="http://www.cancer.gov/cancertopics/managing-care">Managing Cancer Care</ExternalRef> page.</Para></SummarySection><SummarySection id="_AboutThis_19"><Title>Contact Us</Title><Para id="_AboutThis_20">More information about contacting us or receiving help with the Cancer.gov Web site can be found on our <ExternalRef xref="http://www.cancer.gov/help">Contact Us for Help</ExternalRef> page. Questions can also be submitted to Cancer.gov through the Web site’s <ExternalRef xref="http://www.cancer.gov/contact/email-us">E-mail Us</ExternalRef>.</Para></SummarySection></SummarySection> 

  <SummarySection id="_GetMore_3"><Title>Get More Information From NCI</Title><Para id="_GetMore_15"><Emphasis><Strong>Call 1-800-4-CANCER</Strong></Emphasis></Para><Para id="_GetMore_16">For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time.  A trained Cancer Information Specialist is available to answer your questions.</Para><Para id="_GetMore_25"><Emphasis><Strong>Chat online 
</Strong></Emphasis></Para><Para id="_GetMore_26">The <ExternalRef xref="https://livehelp.cancer.gov/">NCI's LiveHelp®</ExternalRef> online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer.
</Para><Para id="_GetMore_27"><Emphasis><Strong>Write to us</Strong></Emphasis></Para><Para id="_GetMore_28">For more information from the NCI, please write to this address:</Para><ItemizedList id="_GetMore_29" Style="simple"><ListItem>NCI Public Inquiries Office</ListItem><ListItem>9609 Medical Center Dr. </ListItem><ListItem>Room 2E532 MSC 9760</ListItem><ListItem>Bethesda, MD 20892-9760</ListItem></ItemizedList><Para id="_GetMore_17"><Emphasis><Strong>Search the NCI Web site</Strong></Emphasis></Para><Para id="_GetMore_18">The <ExternalRef xref="http://cancer.gov">NCI Web site</ExternalRef> provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support and resources for cancer patients and their families.  For a quick search, use the search box in the upper right corner of each Web page. The results for a wide range of search terms will include a list of "Best Bets," editorially chosen Web pages that are most closely related to the search term entered.</Para><Para id="_GetMore_30">There are also many other places to get materials and information about cancer treatment and services.      Hospitals in your area may have information about  local and regional agencies that have information on finances, getting to and from treatment, receiving care at home, and dealing with problems related to cancer treatment.</Para><Para id="_GetMore_19"><Emphasis><Strong>Find Publications</Strong></Emphasis></Para><Para id="_GetMore_20">The NCI has booklets and other materials for patients, health professionals, and the public.  These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials.  Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities.  NCI materials on these and other topics may be ordered online or printed directly from the <ExternalRef xref="https://pubs.cancer.gov/ncipl">NCI Publications Locator</ExternalRef>. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237).</Para></SummarySection><PatientVersionOf ref="CDR0000062881"/><DateLastModified>2015-05-26</DateLastModified></Summary>
